title: Why Johnson & Johnson Is Eyeing Protagonist Therapeutics: The Rationale
source: SeekingAlpha
date: 2025-10-13
url: https://finnhub.io/api/news?id=be81204fbb2c28eb3f73544477af25c7e29bb550f43adab1421f704877bb523b
Protagonist Therapeutics eyes a Johnson & Johnson buyout interest, with blockbuster drug potential and high acquisition hopes. Find out why PTGX stock is a buy.
